The management of anal squamous cell carcinoma (ASCC) has yet to experience the
transformative impact of precision medicine. Conducting genomic analyses may uncover …

Background: A better understanding of the molecular profile of anal squamous cell
carcinomas (ASCCs) is necessary to consider new therapeutic approaches, and the …

Anal squamous cell carcinoma (ASCC) is a rare tumor of the gastrointestinal tract. We aimed
to compare the genetic backgrounds and their effect on clinical outcomes between …

Anal squamous cell carcinomas (ASCC) are rare tumours in humans. The etiological role of
HPV infection is now well established but little is known about the molecular landscape and …

Background Squamous cell cancers of the anal canal (ASCC) are increasing in frequency
and lack effective therapies for advanced disease. Although an association with human …

Anal cancer is a rare disease that has doubled in incidence over the last four decades.
Current treatment and survival of patients with this disease has not changed substantially …

Genomic alterations of anal squamous cell carcinoma (ASCC) remain poorly understood
due to the rarity of this tumor. Array comparative genomic hybridization and targeted gene …

Squamous cell carcinoma of the anal canal (SCCA) is a rare gastrointestinal malignancy
with an increasing annual incidence globally. The majority of cases are linked to prior …

Squamous cell carcinoma of the anal canal (SCCA) is a rare neoplasm, but with rising
incidence rates in the past few decades; it is etiologically linked with the human …

Purpose: Squamous cell carcinoma of the anal canal (ASCC) accounts for 2% to 4% of
gastrointestinal malignancies in the United States and is increasing in incidence; however …